249 related articles for article (PubMed ID: 305953)
1. Diagnosis of exocrine pancreatic insufficiency in cystic fibrosis by the synthetic peptide N-benzoyl-L-tyrosyl-p-aminobenzoic acid.
Nousia-Arvanitakis S; Arvanitakis C; Desai N; Greenberger NJ
J Pediatr; 1978 May; 92(5):734-7. PubMed ID: 305953
[TBL] [Abstract][Full Text] [Related]
2. PABA screening test for exocrine pancreatic function in infants and children.
Sacher M; Kobsa A; Shmerling DH
Arch Dis Child; 1978 Aug; 53(8):639-41. PubMed ID: 309317
[TBL] [Abstract][Full Text] [Related]
3. [The PABA-peptide test: a method in diagnosis of exocrine pancreatic insufficiency (author's transl)].
Schneiber E; Burgislaus E
Med Klin; 1979 Jun; 74(25):1000-3. PubMed ID: 314038
[TBL] [Abstract][Full Text] [Related]
4. Specificity of the BT-PABA test for the diagnosis of exocrine pancreatic insufficiency in the dog.
Batt RM; Mann LC
Vet Rec; 1981 Apr; 108(14):303-7. PubMed ID: 6972120
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of postoperative exocrine pancreatic function using chymotrypsin labile peptide.
Manabe T; Yokota T; Tobe T
Jpn J Surg; 1982; 12(3):178-83. PubMed ID: 6982366
[TBL] [Abstract][Full Text] [Related]
6. Bentiromide test for assessing pancreatic dysfunction using analysis of para-aminobenzoic acid in plasma and urine. Studies in cystic fibrosis and Shwachman's syndrome.
Weizman Z; Forstner GG; Gaskin KJ; Kopelman H; Wong S; Durie PR
Gastroenterology; 1985 Sep; 89(3):596-604. PubMed ID: 3874804
[TBL] [Abstract][Full Text] [Related]
7. Colorimetric plasma assay for the bentiromide test (BT-PABA) for exocrine pancreatic insufficiency.
Gharbo SA; Boyer JA; Williamson MJ
Anal Biochem; 1985 Jul; 148(1):228-32. PubMed ID: 3876041
[TBL] [Abstract][Full Text] [Related]
8. Residual function of exocrine pancreas after operation for chronic pancreatitis by N-benzoyl-L-tyrosyl-p-aminobenzoic acid test (NBT-PABA test).
Kodama M; Tanaka T
Digestion; 1984; 30(1):41-6. PubMed ID: 6333364
[TBL] [Abstract][Full Text] [Related]
9. BT-Paba test in the diagnosis of pancreatic exocrine insufficiency in cystic fibrosis: urinary and serum determinations compared.
Bellentani S; Grisendi A; Rinaldi M; Bertolani P; Costa G; Agostini M; Mastella G; Balli F; Manenti F
Eur J Pediatr; 1984 Dec; 143(2):145-8. PubMed ID: 6335090
[TBL] [Abstract][Full Text] [Related]
10. Failure of p-aminobenzoic acid screening test to diagnose pancreatic insufficiency in Shwachman's syndrome.
Kai H; Nose O; Harada T; Maki I; Tajiri H; Yabuuchi H
J Pediatr Gastroenterol Nutr; 1982; 1(3):445-8. PubMed ID: 6985261
[TBL] [Abstract][Full Text] [Related]
11. Assessment of exocrine pancreatic function by oral administration of N-benzoyl-L-tyrosyl-p-aminobenzoic acid (Bentiromide): 5 years' clinical experience.
Lang C; Gyr K; Stalder GA; Gillessen D
Br J Surg; 1981 Nov; 68(11):771-5. PubMed ID: 6975148
[TBL] [Abstract][Full Text] [Related]
12. [Clinical studies on the exocrine pancreatic function test by oral administration of N-benzoyl-L-tyrosyl-PABA combined with the PABA absorption test (author's transl)].
Kimura T; Wakasugi H; Funakoshi A; Matsumoto M; Ibayashi H
Nihon Shokakibyo Gakkai Zasshi; 1979 Feb; 76(2):259-65. PubMed ID: 312346
[No Abstract] [Full Text] [Related]
13. Determination of protease-cleaved p-aminobenzoic acid (PABA) in serum after oral administration of N-benzoyl-L-tyrosyl-p-aminobenzoic acid (PABA-peptide) in children.
Dockter G; Nacu I; Kohlberger E
Eur J Pediatr; 1981 Feb; 135(3):277-9. PubMed ID: 6971754
[TBL] [Abstract][Full Text] [Related]
14. Hydrolysis and metabolism of N-benzoyl-L-tyrosyl-p-aminobenzoic acid in normal and pancreatic duct-ligated animals.
Yamato C; Kinoshita K
J Pharmacol Exp Ther; 1978 Aug; 206(2):468-74. PubMed ID: 682127
[TBL] [Abstract][Full Text] [Related]
15. Study on the exocrine pancreatic function by the oral administration of N-benzoyl-L-tyrosyl-para-aminobenzoic acid.
Kato K; Izumiyama S; Sakakura M; Hirayama A; Ishii K
Gastroenterol Jpn; 1977; 12(4):289-92. PubMed ID: 304023
[TBL] [Abstract][Full Text] [Related]
16. Two indirect tests of exocrine pancreatic function evaluated.
Scharpé S; Iliano L
Clin Chem; 1987 Jan; 33(1):5-12. PubMed ID: 3542296
[TBL] [Abstract][Full Text] [Related]
17. Altered PABA pharmacokinetics in cystic fibrosis. Implications for bentiromide test.
Koren G; Weizman Z; Forstner G; MacLeod SM; Durie PR
Dig Dis Sci; 1985 Oct; 30(10):928-32. PubMed ID: 3875462
[TBL] [Abstract][Full Text] [Related]
18. [The PABA test].
Müller G; Biering A; Graubaum K; Jeschkeit H; Neubert K; Kleine R; Klapperstück M
Dtsch Z Verdau Stoffwechselkr; 1984; 44(5):219-31. PubMed ID: 6334604
[TBL] [Abstract][Full Text] [Related]
19. Non-pancreatic hydrolysis of N-benzoyl-l-tyrosyl-p-aminobenzoic acid (PABA-peptide) in the human small intestine.
Sterchi EE; Green JR; Lentze MJ
Clin Sci (Lond); 1982 May; 62(5):557-60. PubMed ID: 7042181
[TBL] [Abstract][Full Text] [Related]
20. The BTPABA pancreatic function test in giardiasis.
Okada M; Fuchigami T; Ri S; Kohrogi N; Omae T
Postgrad Med J; 1983 Feb; 59(688):79-82. PubMed ID: 6601797
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
